USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 2, 2021 | Sep 2021 | $0.28 | $0.38 | $0.21 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 2, 2021 | Sep 2021 | $638.43M | $617.02M | $284.40M |
Adapthealth Corp's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $0.31 | $0.20 | $0.38 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $1.00 | $0.72 | $1.36 |
| Dec 2022 | 6 | $1.38 | $0.83 | $1.73 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $0.31 | $0.33 | $0.33 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $1.00 | $0.73 | $0.74 |
| Dec 2022 | 0 / 0 | $1.38 | $1.35 | $1.38 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 9 | $677.87M | $633.39M | $715.17M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 9 | $2.41B | $2.36B | $2.46B |
| Dec 2022 | 10 | $2.74B | $2.62B | $2.82B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 2, 2021 | Sep 2021 | $0.28 | - | - |
| Aug 5, 2021 | Jun 2021 | $0.26 | $0.38 | 45.95% |
| May 6, 2021 | Mar 2021 | $0.26 | $0.20 | -23.53% |
| Mar 4, 2021 | Dec 2020 | $0.23 | $0.44 | 93.25% |
| Nov 4, 2020 | Sep 2020 | $0.13 | $0.21 | 67.09% |
| Aug 4, 2020 | Jun 2020 | $0.16 | $0.16 | -1.48% |
| May 5, 2020 | Mar 2020 | $0.08 | $0.02 | -73.33% |
| Feb 25, 2020 | Dec 2019 | $0.10 | $0.08 | -21.02% |
| Nov 13, 2019 | Sep 2019 | - | $-0.00 | - |
| Dec 31, 2018 | Dec 2018 | - | $0.02 | - |
| Sep 30, 2018 | Sep 2018 | - | $0.02 | - |
| Jun 30, 2018 | Jun 2018 | - | $0.02 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 4, 2021 | Dec 2020 | $0.23 | $0.83 | 261.52% |
| Feb 25, 2020 | Dec 2019 | $0.09 | $0.07 | -21.11% |
| Dec 31, 2018 | Dec 2018 | - | $0.06 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 2, 2021 | Sep 2021 | $638.43M | - | - |
| Aug 5, 2021 | Jun 2021 | $617.02M | $617.02M | 1.00% |
| May 6, 2021 | Mar 2021 | $486.34M | $482.12M | 0.99% |
| Mar 4, 2021 | Dec 2020 | $323.09M | $348.43M | 1.08% |
| Nov 4, 2020 | Sep 2020 | $265.31M | $284.40M | 1.07% |
| Aug 4, 2020 | Jun 2020 | $196.28M | $232.12M | 1.18% |
| May 5, 2020 | Mar 2020 | $177.40M | $191.44M | 1.08% |
| Feb 25, 2020 | Dec 2019 | $142.26M | $529.64M | 3.72% |
| Nov 13, 2019 | Sep 2019 | - | $0.00 | - |
| Dec 31, 2018 | Dec 2018 | - | $105.40M | - |
| Sep 30, 2018 | Sep 2018 | - | $102.16M | - |
| Jun 30, 2018 | Jun 2018 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 4, 2021 | Dec 2020 | $1.03B | $1.06B | 2.48% |
| Feb 25, 2020 | Dec 2019 | $522.33M | $529.64M | 1.40% |
| Dec 31, 2018 | Dec 2018 | - | $0.00 | - |
AHCO's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 5 analysts, the average EPS estimation for Adapthealth Corp's next quarterly earnings is $0.28, with a low EPS estimation of $0.17, and a high estimation of $0.37.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.28, the last 2 month trend is $0.26, and the 3 month trend is $0.26.
Based on 7 analysts, the average revenue estimation is $638.43M, with a low revenue estimation of $619.40M, and a high estimation of $661.40M.
Adapthealth Corp's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.
AHCO's earnings per share (EPS) was $0.38, beating the consensus analysts forecast of $0.26 by 45.95%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by 86.82%, and higher than the same period a year before (Jun 2020) by 135.48%.
Revenues were $617.02M, better than the forecast of $617.02M by 0.00%, up by 27.98% from the previous quarter , and up by 165.82% from the same period last year.
The company reported a net income of $79.11M.Free cash flow for the quarter was $85.44M , compared to $-17.22M last quarter and $83.25M a year before.
AHCO ended the quarter with $1.90B in total debt, an increase of 6.19% compared to the previous quarter, and an increase of 305.31% compared to the same quarter a year before.
Adapthealth Corp's previous annual earnings date was Mar 4, 2021 for its fiscal year ended Dec 31, 2020.
AHCO's earnings per share (EPS) was $0.83, beating the consensus analysts forecast of $0.23 by 261.52% , and higher than the previous year's EPS (Dec 2019) by 1071.13%.
Revenues were $1.06B, better than the forecast of $1.03B by 2.48%, and up by 99.45% from previous year's revenue.
The company reported a net income of $-64.48M.
Adapthealth Corp reported a free cash flow of $155.88M for its fiscal year, compared to $39.09M a year ago.
The company ended the fiscal year with $807.00M in total debt, an increase of 93.72% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
